Pfizer’s Updated Booster Targets Omicron Variants, New Data Confirms
FRIDAY, Oct. 14, 2022 (HealthDay News) — New trial data shows that Pfizer’s updated COVID booster shot is more powerful against Omicron subvariants than the original shot, the company announced Thursday.The findings are reassuring, since human data o…
Learn MoreWith Tough Flu Season Already Here, An Expert Answers Your Flu Shot Questions
FRIDAY, Oct. 14, 2022 (HealthDay News) — Indications are that this year’s flu season is going to be particularly nasty, making the annual influenza vaccine even more important than usual, infectious disease experts say.People already are landing in t…
Learn MoreMisrepresentation, Nonadherence to COVID-19 Public Health Measures Common
THURSDAY, Oct. 13, 2022 (HealthDay News) — Four in 10 U.S. adults report misrepresentation and/or nonadherence to public health measures against COVID-19, according to a study published online Oct. 10 in JAMA Network Open.Andrea Gurmankin Levy, Ph.D….
Learn MoreLa FDA aprueba un nuevo refuerzo bivalente contra la COVID para su uso en niños
MIÉRCOLES, 12 de octubre de 2022 (HealthDay News) — El nuevo refuerzo bivalente contra la COVID-19 cuenta ahora con la aprobación para niños de incluso apenas 5 años, anunció el miércoles la Administración de Alimentos y Medicamentos (FDA) de EE. UU….
Learn MoreCOVID Drug Paxlovid Might Interact With Heart Meds
THURSDAY, Oct. 13, 2022 (HealthDay News) — The COVID-19 antiviral Paxlovid has been a game-changer in the global pandemic, shielding high-risk patients from the coronavirus’ most devastating effects.But Paxlovid can itself pose a risk for people taki…
Learn MoreNearly Half of Long COVID Sufferers Still Haven’t Recovered Months Later
THURSDAY, Oct. 13, 2022 (HealthDay News) — Nearly one of every 20 people who had COVID still haven’t recovered completely from their initial infection six to 18 months later, a new study shows, while another 42% say they have only recovered partially…
Learn MoreFDA Approves New Bivalent COVID-19 Booster for Use in Children
WEDNESDAY, Oct. 12, 2022 (HealthDay News) — The new bivalent COVID-19 booster is now approved for children as young as 5 years old, the U.S. Food and Drug Administration announced Wednesday.The bivalent booster shot includes one part that protects ag…
Learn MoreFDA Approves New Bivalent COVID Booster for Use in Children
WEDNESDAY, Oct. 12, 2022 (HealthDay News) — The new bivalent COVID-19 booster is now approved for children as young as 5 years old, the U.S. Food and Drug Administration announced Wednesday.The bivalent booster shot includes one part that protects ag…
Learn MoreEarly Steroid Use Does Not Cut Hospital Stay for Non-MIS-C COVID-19
TUESDAY, Oct. 11, 2022 (HealthDay News) — Early use of steroids seems not to reduce hospital length of stay (LOS) for non-multisystem inflammatory syndrome in children (MIS-C) COVID-19 in children, according to a study published online Oct. 3 in JAMA…
Learn MoreMuchos estadounidenses mintieron sobre la COVID, según un estudio
LUNES, 10 de octubre de 2022 (HealthDay News) — En el punto álgido de la pandemia de COVID-19, más de un 40 por ciento de los estadounidenses mintieron respecto a si tenían o no el virus, o ignoraban las medidas de seguridad, muestra una encuesta nac…
Learn More